Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Jamerson

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Blood Pressure|April 25, 2007
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular riskMichael A Weber, George L Bakris, Björn Dahlöf, et al.
Journal of the American College of Cardiology|December 15, 2015
Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure GradientTimothy P Murphy, Christopher J Cooper, Alan H Matsumoto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 9, 2018
Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney DiseaseJoshua D Bundy, Lydia A Bazzano, Dawei Xie, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 12, 2013
Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) studyTimothy P Murphy, Christopher J Cooper, Donald E Cutlip, et al.
Journal of the American Heart Association|October 1, 2017
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart AssociationGlenn N Levine, Richard A Lange, C Noel Bairey-Merz, et al.
The American Journal of Cardiology|December 16, 2011
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertensionStevo Julius, Paolo Palatini, Sverre E Kjeldsen, et al.
Blood Pressure|July 9, 2008
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialSverre E Kjeldsen, Gordon T McInnes, Giuseppe Mancia, et al.
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Use of renin-angiotensin inhibitors in people with renal artery stenosisKaleigh L Evans, Katherine R Tuttle, David A Folt, et al.
Blood Pressure|August 6, 2025
On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE TrialEirik Olsen, Julian E Mariampillai, Roland E Schmieder, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Blood Pressure|April 25, 2007
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular riskMichael A Weber, George L Bakris, Björn Dahlöf, et al.
Journal of the American College of Cardiology|December 15, 2015
Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure GradientTimothy P Murphy, Christopher J Cooper, Alan H Matsumoto, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 9, 2018
Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney DiseaseJoshua D Bundy, Lydia A Bazzano, Dawei Xie, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 12, 2013
Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) studyTimothy P Murphy, Christopher J Cooper, Donald E Cutlip, et al.
Journal of the American Heart Association|October 1, 2017
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart AssociationGlenn N Levine, Richard A Lange, C Noel Bairey-Merz, et al.
The American Journal of Cardiology|December 16, 2011
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertensionStevo Julius, Paolo Palatini, Sverre E Kjeldsen, et al.
Blood Pressure|July 9, 2008
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialSverre E Kjeldsen, Gordon T McInnes, Giuseppe Mancia, et al.
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 7, 2014
Use of renin-angiotensin inhibitors in people with renal artery stenosisKaleigh L Evans, Katherine R Tuttle, David A Folt, et al.
Blood Pressure|August 6, 2025
On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE TrialEirik Olsen, Julian E Mariampillai, Roland E Schmieder, et al.
Pageof 5